Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Acetone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.44 |
| ▸ | CHRM4 known ✓ | P08173 | 2/20 | 0.44 |
| ▸ | CHRM5 known ✓ | P08912 | 2/20 | 0.44 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.44 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.44 |
| ▸ | MMP1 known ✓ | P03956 | 1/20 | 0.33 |
| ▸ | MMP8 known ✓ | P22894 | 1/20 | 0.33 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.31 |
| ▸ | AGTR1 known ✓ | P30556 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL3715272 | 0.96 | LMNA (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL6546388 | 0.94 | FFAR3 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetone SCHEMBL11644767 | 0.93 | CHRM2 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetone SCHEMBL27728650 | 0.93 | CHRM2 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL6368562 | 0.90 | FFAR3 (0.47) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL599872 | 0.90 | FFAR3 (0.47) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetone SCHEMBL6764043 | 0.88 | CHRM1 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetone SCHEMBL8644179 | 0.87 | CHRM2 (0.41) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL3884321 | 0.87 | FFAR3 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL19356582 | 0.86 | FFAR3 (0.50) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112939941-A | Preparation method of lansoprazole | 珠海润都制药股份有限公司 | 2021-06-11 | — | — | CN | claimed |
| CN-209039373-U | A kind of novel acetone-triethylamine-water mixed system separator | 浙江新创兴科技有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-101712687-B | Method for preparing intermediate of cefetamet pivoxil hydrochloride | SHANGDONG NEW TIME PHARM PROD | 2012-08-29 | — | — | CN | claimed |
| CN-101712687-A | Method for preparing intermediate of cefetamet pivoxil hydrochloride | SHANDONG XINSHIDAI PHARMACEUTI | 2010-05-26 | — | — | CN | claimed |
| CN-112939941-A | Preparation method of lansoprazole | 珠海润都制药股份有限公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-209039373-U | A kind of novel acetone-triethylamine-water mixed system separator | 浙江新创兴科技有限公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-209039373-U | A kind of novel acetone-triethylamine-water mixed system separator | 浙江新创兴科技有限公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-209039373-U | A kind of novel acetone-triethylamine-water mixed system separator | 浙江新创兴科技有限公司 | 2019-06-28 | — | — | CN | disclosed |
| EP-2397485-B1 | Steviol glycoside isomers | PEPSICO INC (US) | 2016-07-13 | — | — | EP | disclosed |
| CN-101712687-B | Method for preparing intermediate of cefetamet pivoxil hydrochloride | SHANGDONG NEW TIME PHARM PROD | 2012-08-29 | — | — | CN | disclosed |
| US-8158181-B2 | Method to make steviol glycoside isomers | PEPSICO, INC. (US) | 2012-04-17 | — | — | US | disclosed |
| EP-2397485-A1 | Steviol glycoside isomers | PepsiCo, Inc. (US) | 2011-12-21 | — | — | EP | disclosed |
| US-7964232-B2 | Steviol glycoside isomers | PEPSICO, INC. (US) | 2011-06-21 | — | — | US | disclosed |
| CN-101712687-A | Method for preparing intermediate of cefetamet pivoxil hydrochloride | SHANDONG XINSHIDAI PHARMACEUTI | 2010-05-26 | — | — | CN | disclosed |
| CN-101565414-A | Method for extracting and separating procyanidine | SHANXI COAL CHEM INST (CN) | 2009-10-28 | — | — | CN | disclosed |
| US-20090074935-A1 | STEVIOL GLYCOSIDE ISOMERS | PEPSICO, INC. (US) | 2009-03-19 | — | — | US | disclosed |
| EP-1914223-A1 | Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use | CRODA INTERNATIONAL plc (GB) | 2008-04-23 | — | — | EP | disclosed |
| US-6956059-B2 | Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use | CRODA INTERNATIONAL, PLC (GB) | 2005-10-18 | — | — | US | disclosed |
| US-20040242663-A1 | Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use | CRODA INTERNATIONAL, PLC (GB) | 2004-12-02 | — | — | US | disclosed |
| CN-1514822-A | Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use | ����˹���ʹ�˾ | 2004-07-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242663-A1 | Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use | ARG1, IL6, IL4I1 | CHRM2 1134/4885CHRM4 2897/4885CHRM5 1345/4885 |
| US-20090074935-A1 | STEVIOL GLYCOSIDE ISOMERS | DEGS1, TAS1R2, TAS2R1 | CHRM2 2356/4885CHRM4 4329/4885CHRM5 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.